Effect of selenium supplementation on mice infected with LP-BM5 MuLV, a murine AIDS model

被引:15
作者
Chen, CY [1 ]
Zhou, JY
Xu, HB
Jiang, Y
Zhu, GF
机构
[1] Huazhong Univ Sci & Technol, Dept Chem, Wuhan 430074, Peoples R China
[2] Chinese Acad Mil Med Sci, Inst Microbiol, Beijing 100071, Peoples R China
关键词
selenium supplementation; LP-BM5; MuLV; MAIDS; oxidative stress;
D O I
10.1007/BF02783244
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
LP-BM5 Murine leukemia virus (MuLV) infection of C57BL/6 mice develop a disease that has many features in common with human acquired immunodeficiency syndrome (AIDS), in particular abnormal lymphoproliferation and severe immunodeficiency. Thus, this MAIDS model may be useful for evaluation of potent antirival agents in vivo. Deficiency in antioxidant micronutients such as selenium, zinc, and glutathione have been observed in AIDs and AIDS-related complex (ARC) patients. In the present study, the MAIDS model was used to evaluate immunological and oxidative effect of Se as sodium selenite. Results indicated that Se treatment 0.1 mg/kg/d (p.o.) inhibited splenomegaly and sera IgG elevation effectively In addition to abnormal immunity, oxidative imbalance possibly existed in MAIDS model, as lipid peroxide increased significantly in spleen and whole blood glutathione peroxidase (GSH-Px) activity decreased markedly. Se supplementation had good protective effect.
引用
收藏
页码:187 / 193
页数:7
相关论文
共 25 条
[1]   IN-VITRO AND IN-VIVO ENHANCEMENT OF DDI-ACTIVITY AGAINST RAUSCHER MURINE LEUKEMIA-VIRUS BY RIBAVIRIN [J].
ALLEN, LB ;
QUENELLE, DC ;
WESTBROOK, L ;
TAYLOR, BA ;
PRICHARD, MN ;
BRAZIER, AD ;
HOLLINGSHEAD, MG ;
SHANNON, WM .
ANTIVIRAL RESEARCH, 1995, 27 (03) :317-323
[2]  
CERNY A, J IFNECT DIS, V166, P285
[3]   SERUM SELENIUM PREDICTS OUTCOME IN HIV-INFECTION [J].
CONSTANS, J ;
PELLEGRIN, JL ;
SERGEANT, C ;
SIMONOFF, M ;
PELLEGRIN, I ;
FLEURY, H ;
LENG, B ;
CONRI, C .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 (03) :392-392
[4]   ABNORMALITIES OF BLOOD SELENIUM AND GLUTATHIONE-PEROXIDASE ACTIVITY IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME AND AIDS-RELATED COMPLEX [J].
DWORKIN, BM ;
ROSENTHAL, WS ;
WORMSER, GP ;
WEISS, L ;
NUNEZ, M ;
JOLINE, C ;
HERP, A .
BIOLOGICAL TRACE ELEMENT RESEARCH, 1988, 15 :167-177
[5]   ANTIOXIDANT STATUS AND LIPID-PEROXIDATION IN PATIENTS INFECTED WITH HIV [J].
FAVIER, A ;
SAPPEY, C ;
LECLERC, P ;
FAURE, P ;
MICOUD, M .
CHEMICO-BIOLOGICAL INTERACTIONS, 1994, 91 (2-3) :165-180
[6]   THE ROLE OF REACTIVE OXYGEN SPECIES, ANTIOXIDANTS AND PHYTOPHARMACEUTICALS IN HUMAN-IMMUNODEFICIENCY-VIRUS ACTIVITY [J].
GREENSPAN, HC .
MEDICAL HYPOTHESES, 1993, 40 (02) :85-92
[7]   EFFECT OF DIETARY SELENIUM ON ERYTHROCYTE AND LIVER GLUTATHIONE PEROXIDASE IN RAT [J].
HAFEMAN, DG ;
SUNDE, RA ;
HOEKSTRA, WG .
JOURNAL OF NUTRITION, 1974, 104 (05) :580-587
[8]   REACTIVE OXYGEN SPECIES, ANTIOXIDANTS, AND ACQUIRED-IMMUNODEFICIENCY-SYNDROME - SENSE OR SPECULATION [J].
HALLIWELL, B ;
CROSS, CE .
ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (01) :29-31
[9]  
KOLLER LD, 1986, CLIN EXP IMMUNOL, V63, P570
[10]  
LONGOMBE AO, 1994, TRACE ELEM MED, V11, P99100